HK1045712A1 - Fimh粘附素基疫苗 - Google Patents

Fimh粘附素基疫苗

Info

Publication number
HK1045712A1
HK1045712A1 HK02106978.1A HK02106978A HK1045712A1 HK 1045712 A1 HK1045712 A1 HK 1045712A1 HK 02106978 A HK02106978 A HK 02106978A HK 1045712 A1 HK1045712 A1 HK 1045712A1
Authority
HK
Hong Kong
Prior art keywords
based vaccines
fimh adhesin
fimh
adhesin
vaccines
Prior art date
Application number
HK02106978.1A
Other languages
English (en)
Inventor
J Hultgren Scott
Langermann Solomon
Original Assignee
Medimmune Inc
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune Inc, Univ Washington filed Critical Medimmune Inc
Publication of HK1045712A1 publication Critical patent/HK1045712A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK02106978.1A 1999-07-15 2002-09-25 Fimh粘附素基疫苗 HK1045712A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14401699P 1999-07-15 1999-07-15
PCT/US2000/019402 WO2001005978A1 (en) 1999-07-15 2000-07-14 FimH ADHESIN-BASED VACCINES

Publications (1)

Publication Number Publication Date
HK1045712A1 true HK1045712A1 (zh) 2002-12-06

Family

ID=22506700

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02106978.1A HK1045712A1 (zh) 1999-07-15 2002-09-25 Fimh粘附素基疫苗

Country Status (6)

Country Link
EP (1) EP1194563A1 (zh)
JP (1) JP2003505030A (zh)
AU (1) AU6349700A (zh)
CA (1) CA2379069A1 (zh)
HK (1) HK1045712A1 (zh)
WO (1) WO2001005978A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1313502A4 (en) * 2000-08-18 2005-10-19 Medimmune Inc ADMINISTRATIVE PROCEDURE OF FIMH PROTEIN AS A VACCINE AGAINST HARNWAY INFECTIONS
WO2007148229A2 (en) * 2006-02-22 2007-12-27 Stefan Knight Immunogenic multivalent adhesin particles
US9149522B2 (en) 2013-09-25 2015-10-06 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9017698B2 (en) 2013-09-25 2015-04-28 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9149521B2 (en) 2013-09-25 2015-10-06 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9504743B2 (en) 2013-09-25 2016-11-29 Sequoia Sciences, Inc Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
EP2933263A1 (en) * 2014-04-17 2015-10-21 Universität Zu Köln Vector and method for expressing molecules of interest in a bacterial cell
CN116888140A (zh) * 2021-01-12 2023-10-13 杨森制药公司 FimH突变体、其组合物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995020657A1 (en) * 1994-01-27 1995-08-03 Gx Biosystems A/S Receptor specific bacterial adhesins and their use

Also Published As

Publication number Publication date
JP2003505030A (ja) 2003-02-12
WO2001005978A1 (en) 2001-01-25
EP1194563A1 (en) 2002-04-10
AU6349700A (en) 2001-02-05
CA2379069A1 (en) 2001-01-25

Similar Documents

Publication Publication Date Title
HUP0202885A3 (en) Vaccines
IL145043A0 (en) Vaccine
HUS1300072I1 (hu) Vakcina
HUP0402067A3 (en) Vaccines
HUP0105392A3 (en) Enhanced vaccines
HUP0005010A2 (en) Salmonella vaccine
GB9901254D0 (en) Vaccines
GB9915204D0 (en) Vaccine
GB9822714D0 (en) Vaccines
HK1045712A1 (zh) Fimh粘附素基疫苗
GB9906437D0 (en) Vaccine
GB9913327D0 (en) Vaccine
GB0004533D0 (en) Vaccines
GB9909072D0 (en) Vaccine
GB9909466D0 (en) Vaccines
GB9904048D0 (en) Vaccines
GB9904280D0 (en) Vaccines
GB9904408D0 (en) Vaccine
GB9905511D0 (en) Vaccine
GB9919260D0 (en) Vaccine
GB9918647D0 (en) Vaccine
GB9917144D0 (en) Vaccine
GB9916677D0 (en) Vaccine
GB9915205D0 (en) Vaccine
GB9927336D0 (en) Vaccine